The global infertility treatment devices market was valued at USD 2.09 Billion in 2024, driven by the increasing adoption of advanced reproductive technologies and innovative healthcare solutions across the globe. It is expected to grow at a CAGR of 5.78% during the forecast period of 2025-2034, with the values likely to reach USD 3.67 Billion by 2034.
Infertility Treatment Devices Market Overview
Infertility treatment devices include advanced tools like incubators, microscopes, and injectables that assist in addressing fertility challenges. The demand for infertility treatment devices is primarily driven by the rising infertility rates due to lifestyle changes, stress, and pollution. Trends like AI integration and advancements in microscopy technology are enhancing treatment precision and outcomes. These factors, combined with growing awareness and regulatory approvals, are propelling market growth as healthcare providers increasingly adopt cutting-edge devices to meet the rising demand for effective infertility treatments.
Infertility Treatment Devices Market Growth Drivers
Rising Prevalence of Infertility Rates Drives Market Growth
Infertility rates are rising globally due to modern lifestyle factors such as stress, unhealthy diets, lack of physical activities, and delays in parenthood. Environmental factors like pollution and exposure to harmful chemicals are also significant contributors. According to the World Health Organization (WHO) 2023 data, around 17.7% of the adult population approximately 1 in 6 worldwide experienced infertility, highlighting the need for affordable, high-quality fertility care. This increasing prevalence has underscored the urgency for innovations in infertility treatment devices. Advanced technologies and personalized solutions are being developed to address these challenges and provide effective support to individuals facing infertility.
Integration of Artificial Intelligence and Machine Learning to Meet Increasing Infertility Treatment Devices Market Demand
Artificial intelligence (AI) and machine learning are transforming various medical domains, including infertility treatments. AI significantly enhances embryo selection accuracy and forecasts treatment outcomes. By employing sophisticated algorithms, it can examine extensive data from past in-vitro fertilization (IVF) cycles to uncover patterns, helping identify the most viable embryos for transfer. This approach boosts IVF success rates while minimizing the time and expenses linked to repeated treatment attempts. Additionally, AI improves sperm analysis by offering objective assessments of sperm quality, surpassing traditional methods that are often influenced by human error, people are turning to AI and machines for personalized solutions, speed, and precision. These advancements are significantly boosting the growth of the market.
Infertility Treatment Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Advancements in Microscopy Technology to Propel Market Growth
Microscopy technologies are shaping the market by improving workflow efficiency and accuracy, making them essential for modern infertility treatments. These technologies are gaining traction in the market as they address growing demands for precision and innovation in reproductive healthcare. For instance, in July 2024, Nikon launched the ECLIPSE Ti2-I Motorized Inverted Microscope, designed to streamline ICSI and IMSI workflows in reproductive medicine. The microscope reduced operational steps by approximately 75%, improving efficiency and accuracy in infertility treatments. Its intuitive design featured a touch screen and enhanced optical technology, allowing precise observation of eggs and sperm, including spindle structures. Such innovations address the emphasis on managing the growing workload of embryologists while enhancing micro-insemination accuracy, marking a significant advancement in microscopy technology and boosting market growth.
Launch of Generic Injectables to Propel the Infertility Treatment Devices Market Value
Injectables are being used in infertility treatment as they offer improved treatment outcomes. Their effectiveness and convenience are encouraging more people to opt for these solutions. This growing preference is driving their adoption in the market, making injectables a key component in modern infertility treatment practices. For instance, in February 2024, Lupin launched Ganirelix Acetate Injection, its first peptide-based injectable in the United States after receiving FDA approval. This single-dose prefilled syringe is a generic equivalent of Organon USA’s Ganirelix Acetate Injection and is designed to inhibit premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. This launch strengthened Lupin’s presence in women’s health and highlighted its commitment to innovative healthcare solutions in the global market.
Establishment of Specialized Training Centres to Drive Infertility Treatment Devices Market Growth
Training centres provide advanced facilities, hands-on training, and access to the latest technologies, ensuring precision in infertility treatments. These centres are playing a vital role in the market by enhancing the skills of researchers and practitioners. With the growing demand for improved success rates, people are increasingly relying on these centres to access cutting-edge expertise and better treatment outcomes. For instance, in May 2024, CHA Medical Group opened Korea’s first global infertility training center at the CHA Bio Complex in Gyeonggi Province. The center addressed the lack of specialized training facilities for infertility researchers in Korea. Equipped with advanced technology, the facility provided theoretical and practical training in techniques such as ICSI and embryo biopsy. This initiative aimed to improve researcher skills, enhance pregnancy success rates, and attract domestic and international participants, marking a significant step in advancing infertility treatment standards.
Surge in Regulatory Approvals to Augment the Infertility Treatment Devices Market Size
The market is witnessing a rise in regulatory approvals to meet the growing demand for effective and affordable options. As authorities continue to prioritize patient safety and innovation, devices gaining approval are transforming how infertility treatments are delivered. For instance, in December 2023, the FDA granted clearance to the PherDal Kit, the first sterile at-home insemination kit in the United States. The PherDal Kit was officially launched in October 2024, marking a significant regulatory milestone and expanding accessibility to safe, affordable infertility treatment options in the market.
Infertility Treatment Devices Market Segmentation
Infertility Treatment Devices Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook